Batchimeg Usukhbayar
MSc, PhD (TMM)
Biobanking Lead
I was qualified at the Health Sciences University of Mongolia and followed up with some research fellowships abroad. Since moving to the UK, I started working at the Department of Medical Oncology, Oxford University since 2007. Later I joined Professor Vyas' group to oversee the expanding Haematopoietic cell Biobank, which was central to the research programme in the Vyas Lab and subsequently joined Therapy Acceleration Laboratory.
Recent publications
-
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
Journal article
Jakobsen NA. et al, (2024), Cell Stem Cell, 31, 1127 - 1144.e17
-
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Journal article
Juban G. et al, (2021), Haematologica, 106, 1106 - 1119
-
Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome.
Journal article
Cruz Hernandez D. et al, (2020), Blood, 136, 1460 - 1465
-
Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.
Journal article
Karamitros D. et al, (2018), Nat Immunol, 19, 85 - 97
-
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Journal article
Mettananda S. et al, (2017), Nat Commun, 8